Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-02-10
2000-04-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544331, 544242, 544322, A61K 31506, C07D23902
Patent
active
060515740
ABSTRACT:
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
REFERENCES:
patent: 4713387 (1987-12-01), Watanabe et al.
patent: 5428164 (1995-06-01), Thurkauf et al.
patent: 5573313 (1996-11-01), Fisher et al.
patent: 5587390 (1996-12-01), Salimbeni et al.
patent: 5593991 (1997-01-01), Adams et al.
patent: 5633376 (1997-05-01), Thurkauf et al.
patent: 5883105 (1999-03-01), Anthony
Chem. Abs: Lee et al., 122: 314-567 1995.
Exp. Opin. Ther. Patents (1996) 6(12):1295-1304 Graham et al "Oncologic, Endocrine & Metabolic / Inhibitors of Protein Farnesylation".
J. of Bio. Chem., vol. 268, No. 11, 7617-7620 (1993) Gibbs et al "Selective Inhibition o Farnesyl-Protein Transferase Blocks Ras Processing in Vivo".
J. of Bio. Chem., vol. 269, No. 44, 27706-27714 (1994) James et al "Benzodiazepine Peptidomimetic BZA-5B Interrupts the MAP Kinase Activition Pathway in H-Ras-transformed Rat-1 Cells, but not in Untransformed Cells".
J. of Bio. Chem., vol. 270, No. 11, 6221-6226 (1995) James et al "Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in Vitro".
Science, vol. 260, 1934-1937 (1993) Kohl et al "Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor".
Proc. Natl. Acad. Sci. US, vol. 91, 9141-9145 (1994) Kohl et al "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice".
Nature Medicine, vol. 1, No. 8, 792-797 (1995) Kohl et al "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice".
Cancer Research vol. 55, 5302-5309 (1995) Sepp-Lorenzino et al "A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines".
Chemical Abstracts 8207h, vol. 110 (1989) Takasugi et al "Preparation and testing of pyridlimidazoles as cardiotonics, inflammation inhibitors, and blood platelet aggregation inhibitors".
Daniel Mark R.
Garcia-Rivas J. Antonio
Merck & Co. , Inc.
Muthard David A.
Shah Mukund J.
LandOfFree
Inhibitors of farnesyl-protein transferase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of farnesyl-protein transferase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of farnesyl-protein transferase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336557